[Epigenetic disturbances in systemic lupus erythematosus]

Area of Science:

• Immunology
• Genetics
• Epigenetics

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by uncontrolled immune activation and autoantibody production.
• While genetic factors are implicated, not all genetically predisposed individuals develop SLE, suggesting the role of other regulatory mechanisms.

Purpose of the Study:

• To explore the role of epigenetic dysfunctions in the pathogenesis of systemic lupus erythematosus (SLE).
• To identify key epigenetic mechanisms contributing to immune dysregulation in SLE.

Main Methods:

• Analysis of major epigenetic mechanisms including DNA methylation, histone modification, non-coding RNA expression, and gene imprinting.
• Investigation of specific epigenetic alterations in SLE, such as global hypomethylation on CD4+ T cells, histone hypoacetylation, and X chromosome reactivation.

Main Results:

• Epigenetic changes significantly impact gene expression critical for immune tolerance.
• Identified epigenetic dysfunctions include global hypomethylation, histone hypoacetylation, and altered histone methylation in SLE patients.
• These epigenetic mechanisms interact to modulate the expression of genes involved in cytokine production and B-lymphocyte activation.

Conclusions:

• Epigenetic alterations are crucial in the pathogenesis of SLE, interacting with genetic and environmental factors.
• Understanding these epigenetic dysfunctions offers potential therapeutic targets for SLE management.